The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic role of TP53 variants in the phase III study of FOLFIRI/cetuximab versus FOLFIRI/cetuximab followed by cetuximab (Cet) alone in first-line therapy of patients with RAS and BRAF wild-type (wt) metastatic colorectal cancer (mCRC) (ERMES study).
 
Nicola Normanno
Honoraria - Illumina; Incyte; Lilly; Merck Serono; MSD; Thermo Fisher Scientific
Consulting or Advisory Role - AstraZeneca; Bayer; Biocartis; Incyte; Novartis; Roche
Research Funding - AstraZeneca (Inst); Biocartis (Inst); Illumina (Inst); Incyte (Inst); Merck Serono (Inst); Qiagen (Inst); Roche (Inst); Thermo Fisher Scientific (Inst)
Travel, Accommodations, Expenses - Merck Serono
 
Armando Orlandi
No Relationships to Disclose
 
Evaristo Maiello
No Relationships to Disclose
 
Anna Maria Rachiglio
No Relationships to Disclose
 
Giuseppe Maglietta
No Relationships to Disclose
 
Angela Damato
Travel, Accommodations, Expenses - Incyte; Ipsen; Janssen-Cilag; Lilly
 
Maria Alessandra Calegari
No Relationships to Disclose
 
Lorenzo Antonuzzo
No Relationships to Disclose
 
Roberto Bordonaro
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Janssen-Cilag; Novartis; Pfizer; Roche; Sanofi
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Janssen-Cilag; Novartis; Pfizer; Roche; Sanofi
Speakers' Bureau - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Janssen-Cilag; Novartis; Pfizer; Roche; Sanofi
 
Maria Giulia Zampino
No Relationships to Disclose
 
Stefano Tamberi
No Relationships to Disclose
 
Sara Lonardi
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo; Incyte; Lilly; Merck Serono; Mirati Therapeutics; MSD; SERVIER
Speakers' Bureau - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Lilly; Merck Serono; Mirati Therapeutics; MSD Oncology; Pierre Fabre; Roche; Servier
Research Funding - Amgen; AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Merck Serono; Roche (Inst)
 
Giuseppe Tonini
Consulting or Advisory Role - Italfarmaco; Molteni Farmaceutici; Novartis; Pierre Fabre; Roche
Research Funding - Novartis (Inst); PharmaMar (Inst)
 
Gerardo Rosati
No Relationships to Disclose
 
Tiziana Pia Latiano
No Relationships to Disclose
 
Emiliano Tamburini
No Relationships to Disclose
 
Monica Rosaria Maiello
No Relationships to Disclose
 
Marianeve Carotenuto
No Relationships to Disclose
 
Carlo Barone
No Relationships to Disclose
 
Carmine Pinto
No Relationships to Disclose